Laboratories adopt Digene's Hybrid Capture II HPV ( human papilloma virus) test:
This article was originally published in Clinica
Diagnostic test providers Quest Diagnostics and Laboratory Corporation of America are to offer Digene's Hybrid Capture II HPV test. Gaithersburg, Maryland-based Digene's test can detect the 13 high-risk forms of HPV which are detected in over 99% of cervical cancers and is used in conjunction with the traditional Pap smear. Some 15,000 women are diagnosed with cervical cancer in the US each year. Around 5,000 women die from the condition, which affects 500,000 women worldwide, each year.